{{Rsnum
|rsid=2044117
|Gene=NALCN
|Chromosome=13
|position=101055958
|Orientation=plus
|GMAF=0.1345
|Gene_s=NALCN,NALCN-AS1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 58.0 | 34.8 | 7.1
| HCB | 97.7 | 2.3 | 0.0
| JPT | 100.0 | 0.0 | 0.0
| YRI | 70.7 | 28.6 | 0.7
| ASW | 73.7 | 26.3 | 0.0
| CHB | 97.7 | 2.3 | 0.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 78.2 | 18.8 | 3.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 81.0 | 19.0 | 0.0
| MKK | 77.6 | 21.7 | 0.7
| TSI | 64.7 | 30.4 | 4.9
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=20889312
|Trait=None
|Title=A genome-wide meta-analysis identifies novel loci associated with schizophrenia and bipolar disorder
|RiskAllele=C
|Pval=5E-7
|OR=1.30
|ORtxt=[NR]
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}